This study characterizes the first H6N1 vaccine against human and avian influenza viruses.
H6N1-VLP vaccine induced antibodies that neutralized viruses in vivo and in vitro.
H6N1-VLP antibodies neutralized conserved epitopes in the HA head and stem domains.
VLP antibodies neutralized hemagglutination and replication in cross-clade viruses.